NOWDiagnostics, an Arkansas company that specializes in the development and manufacture of next-generation lateral flow assays, is delighted to announce a partnership with Future Healthcare, a European distribution company headquartered in Portsmouth, England. Future Healthcare will promote and sell NOWDiagnostics’ ADEXUSDx® hCG and Syphilis tests to hospital systems, clinics, and laboratories in the United Kingdom and Ireland. They will also use their well-established direct-to-consumer eCommerce platform to deliver the First To Know® Pregnancy Test, the world’s first CE-marked at-home blood-based early-detection pregnancy test. For months, the companies have been working closely together to exact agreements and develop marketing materials to expand access to best-in-class diagnostic tests in Europe. Both companies share a common mission – to improve patient healthcare outcomes.
NOWDiagnostics COO, Beth Cobb, says “We are thrilled to partner with Future Healthcare to bring low-cost, laboratory-accurate, and easy-to-use diagnostics to our European neighbors. Thank you, Future Healthcare, for joining forces with us to improve patient care.”
